Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Mar. 26, 2022
Cash flows from operating activities:
Net loss	$ (9,132)	$ (1,887)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Depreciation and amortization	32,277	28,775
Deferred income taxes	(2,594)	1,293
Deferred financing and original issue discount amortization	1,332	1,299
Stock-based compensation expense	2,637	6,018
Loss on disposal of property and equipment	82	0
Change in fair value of contingent consideration	1,715	(1,470)
Changes in operating items:
Accounts receivable, net	(33,963)	(22,304)
Inventories, net	38,871	(29,529)
Other assets	(5,934)	(3,854)
Accounts payable	11,406	9,910
Other accrued liabilities	(5,190)	8,207
Net cash provided by (used for) operating activities	31,507	(3,542)
Cash flows from investing activities:
Acquisition of business, net of cash received	(300)	(2,500)
Capital expenditures	(18,111)	(12,541)
Other investing activities	(113)	0
Net cash used for investing activities	(18,524)	(15,041)
Cash flows from financing activities:
Repayments of senior term loans	(2,128)	(2,128)
Borrowings on revolving credit loans	39,000	70,000
Repayments of revolving credit loans	(44,000)	(43,000)
Principal payments under finance lease obligations	(494)	(259)
Proceeds from exercise of stock options	0	328
Payments of contingent consideration	(1,079)	(38)
Other financing activities	(58)	0
Cash payments related to hedging activities	0	(467)
Net cash (used for) provided by financing activities	(8,759)	24,436
Effect of exchange rate changes on cash	(555)	(1,083)
Net increase in cash and cash equivalents	3,669	4,770
Cash and cash equivalents at beginning of period	31,081	14,605
Cash and cash equivalents at end of period	34,750	19,375
Supplemental disclosure of cash flow information:
Income taxes paid	472	370
All Debt Excluding 11.6% Subordinated Debentures
Supplemental disclosure of cash flow information:
Interest paid	$ 15,059	$ 9,681